Exploring rhodanine linked enamine–carbohydrazide derivatives as mycobacterial carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and molecular docking studies
Archiv der Pharmazie · 2024
DOI: 10.1002/ardp.202400064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Sarvan Maddipatla und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Rhodanine, Carbonic Anhydrase Inhibitors, Molecular Docking Simulation, Drug Design. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India, New Delhi.
Abstract (Originalsprache)
With the rise of multidrug‐resistant tuberculosis, the imperative for an alternative and superior treatment regimen, incorporating novel mechanisms of action, has become crucial. In pursuit of this goal, we have developed and synthesized a new series of rhodanine‐linked enamine–carbohydrazide derivatives, exploring their potential as inhibitors of mycobacterial carbonic anhydrase. The findings reveal their efficacy, displaying notable selectivity toward the mycobacterial carbonic anhydrase 2 (mtCA 2) enzyme. While exhibiting moderate activity against human carbonic anhydrase isoforms, this series demonstrates promising selectivity, positioning these compounds as potential antitubercular agents. Compound 6d was the best one from the series with a K i value of 9.5 µM toward mtCA 2. Most of the compounds displayed moderate to good inhibition against the Mtb H37Rv strain; compound 11k showed a minimum inhibitory concentration of 1 µg/mL. Molecular docking studies revealed that compounds 6d and 11k show metal coordination with the zinc ion, like classical CA inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.
- Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Polo Scientifico, Sesto Fiorentino, Firenze, Italy.
- Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.
Förderung
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India, New Delhi
Zitieren
APA
Maddipatla, S., Bakchi, B., Gadhave, R. R., Ammara, A., Sau, S., Rani, B., Nanduri, S., Kalia, N. P., Supuran, C. T., & Yaddanapudi, V. M. (2024). Exploring rhodanine linked enamine–carbohydrazide derivatives as mycobacterial carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and molecular docking studies. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400064
Vancouver
Maddipatla S, Bakchi B, Gadhave RR, Ammara A, Sau S, Rani B, et al. Exploring rhodanine linked enamine–carbohydrazide derivatives as mycobacterial carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and molecular docking studies. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400064
BibTeX
@article{Maddipatla2024,
author = {Maddipatla, Sarvan and Bakchi, Bulti and Gadhave, Rutuja Rama and Ammara, Andrea and Sau, Shashikanta and Rani, Bandela and Nanduri, Srinivas and Kalia, Nitin Pal and Supuran, Claudiu T and Yaddanapudi, Venkata Madhavi},
title = {Exploring rhodanine linked enamine–carbohydrazide derivatives as mycobacterial carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and molecular docking studies},
journal = {Archiv der Pharmazie},
year = {2024},
doi = {10.1002/ardp.202400064}
}
EUVIMED